Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer

Inclusion Criteria:

Ovarian Cancer Participants

   1. Patient is ≥ 18 years old at the time of the drug administration

   2. Participant has suspected or biopsy proven ovarian cancer and is scheduled to undergo
   surgical excision of the cancerous lesion(s) OR Participant has biopsy proven ovarian
   cancer but is not a surgical candidate

   3. Ability to understand and the willingness to sign a written informed consent document.

   4. Patient is able to remain still for duration of each imaging procedure

Breast Cancer Participants

   1. Patient is ≥ 18 years old at the time of the drug administration

   2. Participant has biopsy proven breast cancer and may or may not undergo surgical
   excision of the cancerous lesion(s)

   3. Ability to understand and the willingness to sign a written informed consent document.

   4. Patient is able to remain still for duration of each imaging procedure

Exclusion Criteria:

Ovarian Cancer Participants

   1. Patient is pregnant or breast-feeding

   2. Patients with contraindications for PET/CT or who cannot complete a PET/CT scan or
   other study procedures.

   3. Patients with serious uncontrolled concurrent medical illness that would limit
   compliance with study requirements

   4. Patients participating in other research imaging protocols will be excluded from this
   study.

Breast Cancer Participants

   1. Patient is pregnant or breast-feeding

   2. Patients with contraindications for PET/CT or who cannot complete a PET/CT scan or
   other study procedures.

   3. Patients with serious uncontrolled concurrent medical illness that would limit
   compliance with study requirements

   4. Patients participating in other research imaging protocols will be excluded from this
   study.